Listings Ledger has spun out from the university to commercialise a real-time valuation ticker for privately-owned companies.
Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.
The gains came against a backdrop of falling net profits and cash reserves that will test Karolinska Development as it looks ahead to convertible debt obligations.
Spun out of Inesc Tec under a strategic agreement with Frontier IP, Insignals hopes to commercialise a surgical guidance device for brain implants to treat conditions including Parkinson's.
Indiana University has retooled its entrepreneurial support offering to enhance its services in business case development, executive recruitment and the sourcing of capital.
Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a Boston University-operated body and a $8.5m series A round.
MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients.
US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.